Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients
Clinical trial NCT00128856 · COMPLETED
Trial details
- NCT number
- NCT00128856
- Sponsor
- Spanish Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Primary completion
- 2015-01-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.